776 related articles for article (PubMed ID: 10318658)
1. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
[TBL] [Abstract][Full Text] [Related]
2. Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease.
de Jong SC; Stehouwer CD; van den Berg M; Kostense PJ; Alders D; Jakobs C; Pals G; Rauwerda JA
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1316-24. PubMed ID: 10323785
[TBL] [Abstract][Full Text] [Related]
3. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
[TBL] [Abstract][Full Text] [Related]
4. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.
Postiglione A; Milan G; Ruocco A; Gallotta G; Guiotto G; Di Minno G
Gerontology; 2001; 47(6):324-9. PubMed ID: 11721146
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia, diabetes mellitus, and carotid atherosclerosis independently increase atherosclerotic vascular disease outcome in Japanese patients with end-stage renal disease.
Haraki T; Takegoshi T; Kitoh C; Kajinami K; Wakasugi T; Hirai J; Shimada T; Kawashiri M; Inazu A; Koizumi J; Mabuchi H
Clin Nephrol; 2001 Aug; 56(2):132-9. PubMed ID: 11522090
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
Billion S; Tribout B; Cadet E; Queinnec C; Rochette J; Wheatley P; Bataille P
Nephrol Dial Transplant; 2002 Mar; 17(3):455-61. PubMed ID: 11865092
[TBL] [Abstract][Full Text] [Related]
7. Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients.
Födinger M; Mannhalter C; Wölfl G; Pabinger I; Müller E; Schmid R; Hörl WH; Sunder-Plassmann G
Kidney Int; 1997 Aug; 52(2):517-23. PubMed ID: 9264011
[TBL] [Abstract][Full Text] [Related]
8. The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease.
Verhoef P; Kok FJ; Kluijtmans LA; Blom HJ; Refsum H; Ueland PM; Kruyssen DA
Atherosclerosis; 1997 Jul; 132(1):105-13. PubMed ID: 9247365
[TBL] [Abstract][Full Text] [Related]
9. Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism.
Hustad S; Ueland PM; Vollset SE; Zhang Y; Bjørke-Monsen AL; Schneede J
Clin Chem; 2000 Aug; 46(8 Pt 1):1065-71. PubMed ID: 10926884
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients.
Morelli VM; Lourenço DM; D'Almeida V; Franco RF; Miranda F; Zago MA; Noguti MA; Cruz E; Kerbauy J
Blood Coagul Fibrinolysis; 2002 Apr; 13(3):271-5. PubMed ID: 11943942
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis.
Lim PS; Hung WR; Wei YH
Nephron; 2001 Mar; 87(3):249-56. PubMed ID: 11287760
[TBL] [Abstract][Full Text] [Related]
12. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
[TBL] [Abstract][Full Text] [Related]
13. The effect of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene on homocysteine levels in elderly men and women from the British regional heart study.
Dekou V; Whincup P; Papacosta O; Ebrahim S; Lennon L; Ueland PM; Refsum H; Humphries SE; Gudnason V
Atherosclerosis; 2001 Feb; 154(3):659-66. PubMed ID: 11257267
[TBL] [Abstract][Full Text] [Related]
14. The common mutations C677T and A1298C in the human methylenetetrahydrofolate reductase gene are associated with hyperhomocysteinemia and cardiovascular disease in hemodialysis patients.
Haviv YS; Shpichinetsky V; Goldschmidt N; Atta IA; Ben-Yehuda A; Friedman G
Nephron; 2002 Sep; 92(1):120-6. PubMed ID: 12187094
[TBL] [Abstract][Full Text] [Related]
15. Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease.
Domagala TB; Adamek L; Nizankowska E; Sanak M; Szczeklik A
Blood Coagul Fibrinolysis; 2002 Jul; 13(5):423-31. PubMed ID: 12138370
[TBL] [Abstract][Full Text] [Related]
16. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke.
Pezzini A; Del Zotto E; Archetti S; Negrini R; Bani P; Albertini A; Grassi M; Assanelli D; Gasparotti R; Vignolo LA; Magoni M; Padovani A
Stroke; 2002 Mar; 33(3):664-9. PubMed ID: 11872884
[TBL] [Abstract][Full Text] [Related]
17. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction.
Girelli D; Friso S; Trabetti E; Olivieri O; Russo C; Pessotto R; Faccini G; Pignatti PF; Mazzucco A; Corrocher R
Blood; 1998 Jun; 91(11):4158-63. PubMed ID: 9596662
[TBL] [Abstract][Full Text] [Related]
18. The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion.
Weger M; Stanger O; Deutschmann H; Leitner FJ; Renner W; Schmut O; Semmelrock J; Haas A
Am J Ophthalmol; 2002 Jul; 134(1):57-61. PubMed ID: 12095808
[TBL] [Abstract][Full Text] [Related]
19. Association of methylenetetrahydrofolate reductase gene polymorphism with carotid atherosclerosis depending on smoking status in a Japanese general population.
Inamoto N; Katsuya T; Kokubo Y; Mannami T; Asai T; Baba S; Ogata J; Tomoike H; Ogihara T
Stroke; 2003 Jul; 34(7):1628-33. PubMed ID: 12775885
[TBL] [Abstract][Full Text] [Related]
20. The relationship between riboflavin and plasma total homocysteine in the Framingham Offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene.
Jacques PF; Kalmbach R; Bagley PJ; Russo GT; Rogers G; Wilson PW; Rosenberg IH; Selhub J
J Nutr; 2002 Feb; 132(2):283-8. PubMed ID: 11823591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
